BELLUS Health Inc. (TSE:BLU – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$19.48 and traded as low as C$19.24. BELLUS Health shares last traded at C$19.48, with a volume of 28,666 shares changing hands. BELLUS Health Price Performance The stock’s […]
PJT Partners Dealmaker Davidson to Join Leerink as Co-President bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
BELLUS Health Inc. (TSE:BLU – Get Free Report)’s stock price traded down 0.1% during mid-day trading on Monday . The stock traded as low as C$19.24 and last traded at C$19.48. 28,666 shares changed hands during trading, a decline of 52% from the average session volume of 59,471 shares. The stock had previously closed at […]
By Christian Moess Laursen GSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows a string of pharmaceutical.
The U.S. FDA’s Pulmonary-Allergy Drugs Advisory Committee has a lot to discuss Nov. 17, but only one voting question: Does the evidence demonstrate that Merck & Co. Inc.’s gefapixant provides a clinically meaningful benefit to adults with refractory or unexplained chronic cough?